Staci Nason
Family · Loxahatchee, FLNPI 1508344169
Payments from drug & device makers
Across 173 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$369
- Sanofi$293
- Merck$293
- Johnson & Johnson$264
- Lilly USA, LLC$229
- Bristol Myers Squibb$202
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,27794%
- Education$2266%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 19 | $369 |
| Sanofi | 13 | $293 |
| Merck | 14 | $293 |
| Johnson & Johnson | 14 | $264 |
| Lilly USA, LLC | 10 | $229 |
| Bristol Myers Squibb | 11 | $202 |
| Daiichi Sankyo Inc. | 7 | $135 |
| Jazz Pharmaceuticals Inc. | 6 | $123 |
| Exelixis Inc. | 2 | $123 |
| Pfizer | 6 | $117 |
| Astellas Pharma US Inc | 6 | $117 |
| AstraZeneca | 6 | $107 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $106 |
| Seagen Inc. | 6 | $99 |
| AbbVie | 4 | $97 |
| Mirati Therapeutics, Inc. | 4 | $88 |
| Bayer | 5 | $87 |
| Eisai Inc. | 4 | $84 |
| Amgen | 5 | $79 |
| Incyte Corporation | 3 | $59 |
| Puma Biotechnology, Inc. | 3 | $55 |
| Beigene USA, Inc. | 3 | $47 |
| Ipsen Biopharmaceuticals, Inc | 2 | $44 |
| ADC Therapeutics America, Inc. | 2 | $33 |
| Boehringer Ingelheim | 1 | $32 |
| Dova Pharmaceuticals | 2 | $31 |
| GSK | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| EMD Serono, Inc. | 1 | $25 |
| Sobi, Inc | 1 | $23 |
| Organon | 1 | $17 |
| Mylan Institutional Inc. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Morphosys, US Inc. | 1 | $14 |
| Blueprint Medicines Corporation | 1 | $14 |
| Global Blood Therapeutics, Inc. | 1 | $11 |
How this compares
$3,503 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anagrelide Hcl | 12 | $670 |
Paid to pharmacies, not to this prescriber.
Other family in Loxahatchee
- Rachael BuschLoxahatchee$189K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.